Page last updated: 2024-11-02

oxonic acid and Anemia, Hemolytic

oxonic acid has been researched along with Anemia, Hemolytic in 1 studies

Oxonic Acid: Antagonist of urate oxidase.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research Excerpts

ExcerptRelevanceReference
"Although fatigue was the most frequently encountered toxicity safety profiles were generally predictable and manageable."2.73Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study. ( Cho, EK; Chung, M; Hong, J; Kim, YS; Lee, JH; Lee, WK; Nam, E; Park, J; Park, SH; Shin, DB, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, SH1
Kim, YS1
Hong, J1
Park, J1
Nam, E1
Cho, EK1
Shin, DB1
Lee, JH1
Lee, WK1
Chung, M1

Trials

1 trial available for oxonic acid and Anemia, Hemolytic

ArticleYear
Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study.
    Anti-cancer drugs, 2008, Volume: 19, Issue:3

    Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression;

2008